#TheInnovators Lecture featuring Professor Francisco Valero: The Magic of Multidisciplinarity @USCViterbi @KeckMedUSC @USC

Our friend and world renowned roboticist Professor Francisco Valero of USC Viterbi joins #TheInnovators series to talk about getting out of our comfort zones as we have engineers, physicians, surgeons and nurses come together to make a difference. Here’s to that!

Read More #TheInnovators Lecture featuring Professor Francisco Valero: The Magic of Multidisciplinarity @USCViterbi @KeckMedUSC @USC

66,000 deaths per year: putting pressure on pressure ulcers @KeckMedUSC @NPUAP @SchaefferCenter #TheInnovators

#TheInnovators Series continues with our good friend William V. Padula of @USC’s Schaefer Center for Public Policy. How can 66,000 deaths be prevented per year (more than traffic accidents, incidentally)? Through a lot of little things and sustained pressure. Here’s to innovating our way forward!

Read More 66,000 deaths per year: putting pressure on pressure ulcers @KeckMedUSC @NPUAP @SchaefferCenter #TheInnovators

Prof. David G. Armstrong of @USC @KeckMedUSC wins Top International Award for Intervention to Prevent Amputation in Diabetes @JWCEditor @APMA

David G. Armstrong, Professor of Surgery and Director of the Southwestern Academic Limb Salvage Alliance (SALSA) at Keck School of Medicine of the University of Southern California won the “Best Diabetic Foot Intervention” Award at a Ceremony in London this past week. The honor was directed as his team’s efforts in developing an interdisciplinary hotline […]

Read More Prof. David G. Armstrong of @USC @KeckMedUSC wins Top International Award for Intervention to Prevent Amputation in Diabetes @JWCEditor @APMA

Landmark OVIVA study: Oral vs. IV in Osteomyelitis- No Difference? @NEJM

A landmark study from a large team of UK investigators including our long-time SALSAmigos Profs. Ben Lipsky and Tony Berendt reports no difference in outcomes from Oral vs. IV antimicrobials for bone and joint infections. Bottom line: as we have said for many years- if a patient has a functioning gut…Choose the least complex option. […]

Read More Landmark OVIVA study: Oral vs. IV in Osteomyelitis- No Difference? @NEJM